Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSynthomer Regulatory News (SYNT)

Share Price Information for Synthomer (SYNT)

Share Price is delayed by 15 minutes
Get Live Data
103.20    -5.80 (-5.32%)
Bid:
103.00
Ask:
104.20
Spread: 1.20 (1.165%)
Market Cap: £169.19m
SYNT Live PriceLast checked at - London Stock Exchange

Intraday Synthomer Share Chart

Directorate Changes

30 Jun 2025 07:00

RNS Number : 8596O
Synthomer PLC
30 June 2025
 

Synthomer plcDirectorate changes

 

Synthomer plc ('Synthomer' or the 'Group') today announces the appointment of two independent non-executive directors, Janet Ashdown and Jonathan Silver, who will join the Board on 1 July 2025.

 

Janet Ashdown has significant experience of general management primarily in the process and chemicals industries, as well as environmental and sustainability matters, and has chaired corporate remuneration committees for more than 10 years. Janet had a 30-year executive career at BP plc until 2010, running the UK retail and commercial fuel business in her last role there. She then became chief executive of Harvest Energy, an international private equity-backed business, until 2013. Janet is currently a non-executive director and remuneration committee chair at Victrex plc, a non-executive director and chair of the remuneration and corporate sustainability committees at RHI Magnesita plc and a non-executive director of Stolt-Nielsen plc. She has previously served as a non-executive director and remuneration committee chair of Marshalls plc and SIG plc, and as senior independent director and chair of committees including for health, safety, security and sustainability of the Nuclear Decommissioning Authority, a UK Government arm's length body. Janet holds a BSc in Energy Engineering from the University of Swansea. Janet will join the Synthomer Board's audit, remuneration and nomination committees on appointment and will succeed Holly Van Deursen as Chair of the Remuneration Committee in late 2026.

 

Jonathan Silver has significant international experience in finance and accounting, risk and controls, treasury, investment management and mergers and acquisitions, having served in a variety of senior roles culminating in chief financial officer during his 30-year executive career to 2015 at Laird plc. Prior to this Jonathan held finance roles at the pharmaceutical and agrichemicals group Fisons plc. Jonathan is currently non-executive director, senior independent director and audit committee chair at Spirent Communications plc. Jonathan also serves as a non-executive director and audit committee chair at Baillie Gifford China Growth Trust plc and at Henderson High Income Trust plc, and previously served in the same roles at Invesco Income Growth Trust plc. He is a Chartered Accountant and a member of the Institute of Chartered Accountants of Scotland. Jonathan holds a BA in Business from the University of Strathclyde. Jonathan will join the Synthomer Board's audit, remuneration and nomination committees on appointment and will succeed Ian Tyler as Chair of the Audit Committee later this year.

 

Further to the announcement of 5 March 2025, Ian Tyler will step down from the Board of Synthomer and his roles as Senior Independent Non-executive Director and Audit Committee Chair in December 2025.

 

Further information:

Investors: Faisal Tabbah, Vice President Investor Relations

Tel: +44 (0) 1279 775 306

Media: Nick Hasell, FTI Consulting

Tel: +44 (0) 203 727 1340

 

Notes

Legal Entity Identifier (LEI): 213800EHT3TI1KPQQJ56. Classification as per DTR 6 Annex 1R: 3.1.

 

Synthomer plc is a leading supplier of high-performance, highly specialised polymers and ingredients that play vital roles in key sectors such as coatings, construction, adhesives, and health and protection - growing markets for customers who serve billions of end users worldwide. Headquartered in London, UK and listed there since 1971, we employ c.3,900 employees across our five innovation centres of excellence and 29 manufacturing sites across Europe, North America, Middle East and Asia. With more than 6,000 blue-chip customers and £2.0bn in continuing revenue in 2024, our business is built around three divisions, serving customers in attractive end markets where demand is driven by global megatrends including urbanisation, demographic change, climate change and sustainability, and shifting economic power. In Coatings & Construction Solutions, our specialist polymers enhance the sustainability and performance of a wide range of coatings and construction products. We serve customers in applications including architectural and masonry coatings, mortar modification, waterproofing and flooring, fibre bonding, and energy solutions. In Adhesive Solutions our products help our customers bond, modify and compatibilise surfaces and components for applications including tapes and labels, packaging, hygiene, tyres and plastic modification, improving permeability, strength, elasticity, damping, dispersion and grip. In Health & Protection and Performance Materials we are a world-leading supplier of water-based polymers for medical gloves, and a major European manufacturer of high-performance binders, foams and other products serving customers in a range of end markets. Our purpose is creating innovative and sustainable solutions for the benefit of customers and society. Around 20% of our sales volumes are from new and patent protected products. At our innovation centres of excellence in the UK, China, Germany, Malaysia and Ohio, USA we collaborate closely with our customers to develop new products and enhance existing ones tailored to their needs, with an increasing range of sustainability benefits. Our 2030 decarbonisation targets have been approved by the Science Based Targets initiative as being in line with what the latest climate science says is necessary to meet the goals of the Paris Agreement, and since 2021 we have held the London Stock Exchange Green Economy Mark, which recognises green technology businesses making a significant contribution to a more sustainable, low-carbon economy. Find us at www.synthomer.com or search for Synthomer on LinkedIn.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAPKCBKPBKDNAB
Date   Source Headline
19th Mar 201511:53 amRNSDirector Declaration
18th Mar 20154:47 pmRNSDirector/PDMR Shareholding
13th Mar 20159:35 amRNSHolding(s) in Company
27th Feb 20153:06 pmRNSDirector/PDMR Shareholding
27th Feb 20153:05 pmRNSDirector/PDMR Shareholding
26th Feb 20157:01 amRNSFinal Results
20th Jan 20151:58 pmRNSNotice of Results
16th Jan 20157:00 amRNSTrading update
18th Dec 20147:00 amRNSBoard Changes
18th Nov 20147:00 amRNSAppointment of Group Chief Executive
28th Oct 20147:00 amRNSInterim Management Statement
22nd Oct 20143:00 pmRNSAcquisition
17th Oct 20141:03 pmRNSDirector/PDMR Shareholding
16th Oct 20143:56 pmRNSDirector/PDMR Shareholding
15th Oct 201412:35 pmRNSDirector/PDMR Shareholding
14th Oct 20142:40 pmRNSDirector/PDMR Shareholding
13th Oct 20149:35 amRNSDirector Declaration
11th Aug 20147:00 amRNSInterim Results
11th Jul 20147:00 amRNSTrading update
1st Jul 20147:00 amRNSAdrian Whitfield to step down as CEO
23rd Jun 201412:01 pmRNSHolding(s) in Company
30th May 20149:24 amRNSHolding(s) in Company
15th May 20144:26 pmRNSDirector/PDMR Shareholding
8th May 201411:25 amRNSDirector/PDMR Shareholding
7th May 20144:35 pmRNSDirector/PDMR Shareholding
1st May 20142:47 pmRNSResult of AGM
1st May 20147:00 amRNSInterim Management Statement
14th Apr 20149:23 amRNSHolding(s) in Company
9th Apr 20143:08 pmRNSHolding(s) in Company
9th Apr 201411:26 amRNSHolding(s) in Company
31st Mar 20149:40 amRNSAnnual Financial Report
14th Mar 20144:17 pmRNSHolding(s) in Company
14th Mar 201411:48 amRNSHolding(s) in Company
12th Mar 20142:40 pmRNSDirector/PDMR Shareholding
6th Mar 20144:15 pmRNSDirector/PDMR Shareholding
6th Mar 20144:12 pmRNSDirector/PDMR Shareholding
5th Mar 20147:00 amRNSChanges to Board Committees
4th Mar 20142:14 pmRNSHolding(s) in Company
28th Feb 20147:01 amRNSPreliminary Results
13th Feb 20142:57 pmRNSHolding(s) in Company
16th Jan 20148:53 amRNSHolding(s) in Company
16th Jan 20147:00 amRNSDirectorate Change
6th Dec 20139:34 amRNSHolding(s) in Company
22nd Nov 20134:08 pmRNSHolding(s) in Company
20th Nov 201311:45 amRNSHolding(s) in Company
19th Nov 20137:00 amRNSCapital Markets Day
12th Nov 20135:06 pmRNSHolding(s) in Company
8th Nov 20133:03 pmRNSHolding(s) in Company
7th Nov 20137:00 amRNSInterim Management Statement
29th Oct 20131:45 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.